| 前收市價 | 11.50 |
| 開市 | 11.40 |
| 買盤 | 0.00 |
| 賣出價 | 0.00 |
| 拍板 | 2.50 |
| 到期日 | 2026-01-16 |
| 今日波幅 | 11.40 - 11.50 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
ZacksNovavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
